Latest Period
Q4 2025
Security Snapshot
NextCure, Inc. - Common Stock, $0.001 par value (NXTC) Institutional Ownership
CUSIP: 65343E207
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
24
Shares (Excl. Options)
1,897,561
Price
$14.19
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.001 par value
- Symbol
- NXTC on Nasdaq
- Shares outstanding
- 3,135,972
- Price per share
- $11.03
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,897,561
- Total reported value
- $26,925,657
- % of total 13F portfolios
- 0%
- Share change
- +824,352
- Value change
- +$12,224,139
- Number of holders
- 24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NXTC - NextCure, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 65343E207.
- 24 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 24 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $26,925,657 to $3,610.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 24 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 65343E207?
CUSIP 65343E207 identifies NXTC - NextCure, Inc. - Common Stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 65343E207:
Significant Owners of NextCure, Inc. - Common Stock, $0.001 par value (NXTC) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 10% | $4,715,825 | 363,035 | Ikarian Capital, LLC | 31 Dec 2025 | |||
| Affinity Asset Advisors, LLC | 10% | +40% | $4,375,018 | +$1,966,899 | 348,607 | +82% | Affinity Asset Advisors, LLC | 22 Jan 2026 |
| Simcere Zaiming, Inc. | 13% | $1,696,566 | 338,636 | Simcere Zaiming, Inc. | 20 Jun 2025 | |||
| Squadron Capital Management LLC | 9.9% | +49% | $3,521,940 | +$1,263,485 | 271,127 | +56% | Squadron Master Fund LP | 31 Dec 2025 |
| Sofinnova Venture Partners IX, L.P. | 7.1% | $2,947,939 | 222,654 | Sofinnova Venture Partners IX, L.P. ("SVP IX") | 19 Dec 2025 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 5% | $2,286,980 | 176,057 | SilverArc Capital Management, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 24 institutional investors reported holding 1,897,561 shares of NextCure, Inc. - Common Stock, $0.001 par value (NXTC). This represents 61% of the company’s total 3,135,972 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of NextCure, Inc. - Common Stock, $0.001 par value (NXTC) together control 61% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 7.9% | 247,294 | +29% | 0.25% | $3,509,102 |
| Ikarian Capital, LLC | 7.6% | 238,303 | 0.44% | $3,381,520 | |
| Squadron Capital Management LLC | 7.6% | 236,966 | 0% | 1.5% | $3,362,548 |
| Sofinnova Investments, Inc. | 7.1% | 222,654 | 0% | 0.14% | $3,159,460 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.6% | 176,057 | 0.36% | $2,498,249 | |
| Exome Asset Management LLC | 5.3% | 165,000 | 1.2% | $2,341,350 | |
| Pfizer Inc | 5% | 157,646 | 0% | 0.95% | $2,236,997 |
| AWM Investment Company, Inc. | 3.7% | 117,371 | 0.16% | $1,665,494 | |
| VANGUARD GROUP INC | 2.9% | 91,910 | +35% | 0% | $1,304,203 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.2% | 69,617 | 0.03% | $987,865 | |
| RENAISSANCE TECHNOLOGIES LLC | 1.1% | 33,634 | +19% | 0% | $477,266 |
| BlackRock, Inc. | 0.89% | 27,793 | -11% | 0% | $394,383 |
| ACADIAN ASSET MANAGEMENT LLC | 0.85% | 26,765 | -27% | 0% | $379,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.74% | 23,157 | +19% | 0% | $328,660 |
| CARDIFF PARK ADVISORS, LLC | 0.7% | 21,833 | 0.03% | $309,810 | |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 13,033 | 0% | $184,938 | |
| MARSHALL WACE, LLP | 0.36% | 11,292 | 0% | $160,233 | |
| Sio Capital Management, LLC | 0.35% | 10,940 | 0% | 0.03% | $155,239 |
| BARCLAYS PLC | 0.18% | 5,626 | 0% | 0% | $79,833 |
| UBS Group AG | 0.01% | 338 | -44% | 0% | $4,796 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 173 | +652% | 0% | $2,454 |
| MORGAN STANLEY | 0% | 66 | 0% | $937 | |
| JPMORGAN CHASE & CO | 0% | 61 | 0% | 0% | $866 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 32 | 0% | 0% | $454 |
| Cable Car Capital, LP | 0% | 0 | -100% | $0 |